• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News

11th DNDi Partners’ Meeting celebrates African leadership in innovation for R&D and access to medicines

Home > News

11th DNDi Partners’ Meeting celebrates African leadership in innovation for R&D and access to medicines

Representatives of the health ministries of Uganda, Kenya and Sudan, and the DNDi leadership team greet the Prime Minister of Uganda, the Right Honourable Dr Ruhakana Rugunda
Representatives of the health ministries of Uganda, Kenya and Sudan, and the DNDi leadership team greet the Prime Minister of Uganda, the Right Honourable Dr Ruhakana Rugunda
17 Oct 2018

Meeting opened by Ugandan Prime Minister convenes public & private sector partners from more than 40 countries  

On 4 October 2018, DNDi held its 11th Partners’ Meeting in Kampala, Uganda. The meeting gathered together more than 400 partners and stakeholders from over 150 institutions and more than 40 countries, primarily African.

The event celebrated African leadership in innovation for R&D and access to medicines and was the first of several events planned to mark the occasion of DNDi’s 15th anniversary. Panel discussions highlighted the importance of partnerships and the continuing need to break new ground in African-led R&D, harmonized regulation, and health access strategies for neglected patients that would ultimately provide a template for universal health coverage.

The meeting was opened by the Prime Minister of Uganda, the Right Honourable Dr Ruhakana Rugunda, who called the meeting a “true testament of collaboration and partnership for neglected patients” and reiterated his own government’s commitment to supporting the search for improved treatments for neglected diseases and patients. The Prime Minister’s remarks were prefaced by the Honourable Sarah Opendi, Minister of State for Health, Uganda.

A powerful keynote was delivered by Dr Kelly Chibale, Director of the H3D Centre, the drug discovery institute at the University of Cape Town University, who was recently named by Fortune magazine as one of the top 50 global leaders for 2018. In conversation with Dr Nick White, Chair, DNDi Scientific Advisory Committee, Dr Chibale set the tone for the day with his call for innovation in Africa, by Africa, for Africa and for the world.

A ministerial panel comprising Dr Henry Mwebesa, Director-General Health Services, Ministry of Health, Uganda, Dr Rashid Abdi Aman, the Chief Administrative Secretary, Ministry of Health, Kenya, and the Honourable Abdelhakim Hassan Nugud Salih, the Minister of Health, Gedaref State, Sudan spoke about the urgent need for improved treatments for neglected tropical diseases and for children living with HIV, and their work to increase treatment access and reach elimination goals in their respective countries.

The Partners’ Meeting was the culmination of several days of disease-specific meetings in Kampala and benefited from summary presentations on the progress, challenges and current priorities of several, including: the 25th Leishmaniasis East Africa Platform (LEAP) Meeting; the 5th Joint human African trypanosomiasis Platform-East Africa Network for Trypanosomiasis Scientific Meeting; a meeting of the Onchocerciasis Network; and the first meeting of the Paediatric HIV Network.

Other panels included perspectives from three Eastern African countries on enhancing medical research capacities and a lively conversation among eight speakers, moderated by DNDi Board Chair Dr Marie-Paule Kieny and Executive Director Dr Bernard Pécoul, on building an enabling environment to enhance Africa’s R&D and regulatory capacities.

View the programme for the day’s events.

  • Dr Bernard Pécoul, Executive Director presenting his welcoming remarks.
  • Representatives of the health ministries of Uganda, Kenya and Sudan, and the DNDi leadership team greet the Prime Minister of Uganda, the Right Honourable Dr Ruhakana Rugunda
  • The DNDi leadership team led by Board Chair Dr Marie-Paule Kieny and the Hon. Dr Sarah Opendi, Minister of State for Health, Uganda, look on as The Prime Minister of Uganda, the Rt. Hon. Ruhukana Rugunda, is welcomed to DNDi’s 11th Partnership Meeting
  • Hon. Sarah Opendi, Uganda’s Minister of State for Health, gives a speech about the role of partnership networks in helping to combat neglected diseases in Uganda.
  • The Rt. Hon. Dr Ruhakana Rugunda, Prime Minister, Uganda making his official remarks during the opening ceremony of the DNDi 11th Partners’ Meeting
  • Prof. Asrat Hailu of Addis Ababa University
  • Dr Monique Wasunna, Director of DNDi Africa Regional Office
  • Dr Bernard Pécoul, Executive Director presenting his welcoming remarks.
  • The Prime Minister of Uganda, the Rt. Hon. Ruhakana Rugunda, is greeted by the Minister of Health for Gedaref State, Sudan, as Dr Rashid Abdi Aman, Chief Administrative Secretary, Ministry of Health, Kenya, looks on.
  • Prof. Kelly Chibale of University of Cape Town, South Africa gives a keynote address on innovation in health Research and Development (R&D) in Africa, for Africa.
  • Dr Bernhards Ogutu, holding the microphone, moderates a session on enhancing medical research capacities in Eastern Africa. He is joined by Dr Juliet Mwanga of Epicenter Uganda (on the right), Prof. Celestino Obua of Mbarara University Uganda, and Prof. Ahmed Fahal of MRC Sudan (on the left)
  • Prof. Celestino Obua of Mbarara University Uganda giving a presentation on enhancing medical research capacities in Eastern Africa.
  • Prof. Ahmed Fahal of Mycetoma Research Centre (MRC) Sudan shares his perspective and experience about capacity enhancement around mycetoma R&D related activities.
  • Dr Juliet Mwanga, Director of Epicenter Uganda
  • More than 400 participants from over 40 countries convened for the 11th DNDi Partners’ Meeting.
  • Uganda’s Prime Minister, The Rt. Hon. Dr Ruhakana Rugunda and government delegation joins participants in a group photo.
  • From left, Prof. Kelly Chibale of University of Cape Town, South Africa and Dr Bernhards Ogutu of KEMRI Kenya sharing an interactive moment.
  • Dr Victor Mussime of Makerere University, Uganda, talks to participants about the Paediatric HIV Network, sharing the stage with, from left: Dr Graeme Bilbe, DNDi R&D Director; Dr Florent Mbo, Coordinator, HAT Platform; Dr Charles Mackenzie, Global Alliance for the Elimination of Lymphatic Filariasis; Dr Rashmi Barbhaiya, DNDi Scientific Advisory Committee; and Prof. Asrat Hailu Mekuria, Addis Ababa University, Ethiopia.
  • The closing panel, from left: Co-moderator Dr Marie-Paule Kieny, Chair of DNDi Board; Dr Alwyn Mwinga, patient representative, DNDi Board; Dr Margareth Ndomondo-Sigonda, NEPAD; Dr Els Torreele, MSF Access Campaign; Nevin Bradford, Cipla Africa; Dr Michael Makanga, EDCTP; Dr Dan Hartman, Bill & Melinda Gates Foundation; Dr Luc Kuykens, Sanofi; Dr Sue Kinn, DFID; and co-moderator Dr Bernard Pécoul, DNDi Executive Director.
  • Dr Marie-Paule Kieny, DNDi Board Chair engaging participants during one of the sessions
  • Dr Margareth Ndomondo-Sigonda, African Medicines Regulatory Harmonization, NEPAD
  • Dr Luc Kuykens, Senior Vice-President, Global Health Programmes, Sanofi
  • Dr Sue Kinn, Head of Health Research, DFID
  • Dr Monique Wasunna, Director of DNDi Africa Regional Office with Uganda’s Prime Minister, The Rt. Hon. Dr Ruhakana Rugunda and the government delegation.
  • Dr Monique Wasunna, Director of DNDi Africa Regional Office with Hon.Hon. Sarah Opendi, Minister of State for Health, Uganda.
  • Dr Bernard Pecoul, Executive Director DNDi addresses questions from journalists.
  • Dr Wilfried Mutombo, of the HAT platform, raises a point during the clinical trial training meeting.
  • Dr Olawale Salami, Project Coordinator of the Living Study, sharing a point during one the clinical trial training sessions.
  • Prof. Joseph Olobo of Makerere University, Uganda giving the welcoming remarks during the 25th LEAP Platform Meeting.
  • Prof. Ahmed Musa of the Institute of Endemic Diseases in Sudan presenting an overview of Visceral Leishmaniasis activities in Sudan
  • Participants, drawn from the various disease areas, attending the clinical trial training pose for a group photo.
Partnership Strengthening Capacities Universal Health Coverage Africa Uganda

Read, watch, share

Loading...
Statements
8 May 2025

DNDi’s briefing note for 78th World Health Assembly

Marco Krieger
News
30 Apr 2025

Message on the passing of Dr Marco Aurélio Krieger, Vice-President of Production and Innovation in Health, Fiocruz

Screening activities in village in Guinea
News
25 Apr 2025

Statements from Dr Luis Pizarro and Daisuke Imoto about the Hideyo Noguchi Africa Prize awarded to DNDi

Two man outside of a hospital talking with a nurse
Press releases
24 Apr 2025

Liverpool clinical trial aims to advance life-changing treatment for a deadly parasitic disease

Woman walking in a laboratory
Press releases
23 Apr 2025

DNDi welcomes GHIT support for new project with three Japanese universities to find drug candidates for Chagas disease

Stories
16 Apr 2025

Drug discovery explained: Chagas – How to prove treatments work?

Statements
16 Apr 2025

Statement from the Drugs for Neglected Diseases initiative (DNDi) on the conclusion of WHO Pandemic Agreement negotiations

Press releases
15 Apr 2025

New treatment for cryptococcal meningitis enters Phase II trial as global HIV funding cuts threaten to cause a massive increase in advanced HIV disease

VIEW ALL

Help neglected patients

To date, we have delivered thirteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License